APRUTUMAB IXADOTIN
UNII DDD2AB5TWK

Substance Identification & Data

This profile provides standardized clinical and technical data for Aprutumab Ixadotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DDD2AB5TWK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1708947-48-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
DDD2AB5TWK
CAS Registry Number
1708947-48-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
APRUTUMAB IXADOTIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10383
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Aprutumab Ixadotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

APRUTUMAB IXADOTIN

Common Names & Synonyms

ANTI-FGFR2 ANTIBODY-DRUG CONJUGATE BAY1187982
APRUTUMAB IXADOTIN [INN]
APRUTUMAB IXADOTIN [WHO-DD]

Technical Codes

BAY 1187982
BAY-1187982